ATOS
Atossa Therapeutics
$2.36
+$0.06 (+2.83%)Jul 27, 2026
Key metrics
The numbers that frame ATOS today
- Market cap
- $20.32M
- P/E (TTM)
- -0.5
- EV / FCF
- 0.3
- ROIC
- 2,579%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.70
- 52wk High
- $19.35
Growth
Revenue and earnings trend for ATOS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ATOS
Is Atossa Therapeutics a good buy?
No. Atossa Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of ATOS?
Atossa Therapeutics's market capitalization is $20.32M.
What is the P/E ratio for ATOS stock?
Atossa Therapeutics's current P/E ratio is -0.5.
What is the 52-week high for ATOS stock?
The 52-week high for Atossa Therapeutics is $19.35. The current close of $2.36 is 87.8% below that high.
What is the 52-week low for ATOS stock?
The 52-week low for Atossa Therapeutics is $1.70. The current close of $2.36 is 38.8% above that low.
Does ATOS stock pay dividends?
Atossa Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ATOS?
Atossa Therapeutics's Debt / Equity ratio is 0.